These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 17924536)

  • 21. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1.
    Young PJ; DiDonato CJ; Hu D; Kothary R; Androphy EJ; Lorson CL
    Hum Mol Genet; 2002 Mar; 11(5):577-87. PubMed ID: 11875052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutics development for spinal muscular atrophy.
    Sumner CJ
    NeuroRx; 2006 Apr; 3(2):235-45. PubMed ID: 16554261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
    DiMatteo D; Callahan S; Kmiec EB
    Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of full-length survival motor neuron by polyphenol botanical compounds.
    Sakla MS; Lorson CL
    Hum Genet; 2008 Jan; 122(6):635-43. PubMed ID: 17962980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence.
    Marquis J; Meyer K; Angehrn L; Kämpfer SS; Rothen-Rutishauser B; Schümperli D
    Mol Ther; 2007 Aug; 15(8):1479-86. PubMed ID: 17505471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene.
    Chen HH; Chang JG; Lu RM; Peng TY; Tarn WY
    Mol Cell Biol; 2008 Nov; 28(22):6929-38. PubMed ID: 18794368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.
    Lorson CL; Hahnen E; Androphy EJ; Wirth B
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6307-11. PubMed ID: 10339583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
    Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
    Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy: from gene to therapy.
    Wirth B; Brichta L; Hahnen E
    Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
    Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
    Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The expression of SMN2 gene mRNA in neuron-like cells derived from patients with spinal muscular atrophy].
    Luo XM; Yang XS; Xiao B
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):831-4. PubMed ID: 17217749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intronic element contributes to splicing repression in spinal muscular atrophy.
    Kashima T; Rao N; Manley JL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stat5 constitutive activation rescues defects in spinal muscular atrophy.
    Ting CH; Lin CW; Wen SL; Hsieh-Li HM; Li H
    Hum Mol Genet; 2007 Mar; 16(5):499-514. PubMed ID: 17220171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving concepts on human SMN pre-mRNA splicing.
    Singh RN
    RNA Biol; 2007; 4(1):7-10. PubMed ID: 17592254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
    Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
    Monani UR; Lorson CL; Parsons DW; Prior TW; Androphy EJ; Burghes AH; McPherson JD
    Hum Mol Genet; 1999 Jul; 8(7):1177-83. PubMed ID: 10369862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.
    Skordis LA; Dunckley MG; Yue B; Eperon IC; Muntoni F
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4114-9. PubMed ID: 12642665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.